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ABSTRACT
Objectives: To describe general practitioner (GP)
involvement in the treatment referral pathway for
colorectal cancer (CRC) patients.
Design: A retrospective cohort analysis of linked data.
Setting: A population-based sample of CRC patients
diagnosed from August 2004 to December 2007 in
New South Wales, Australia, using the 45 and Up
Study, cancer registry diagnosis records, inpatient
hospital records and Medicare claims records.
Participants: 407 CRC patients who had a
colonoscopy followed by surgery.
Primary outcome measures: Patterns of GP
consultations between colonoscopy and surgery (ie,
between diagnosis and treatment). We investigated
whether consulting a GP presurgery was associated
with time to surgery, postsurgical GP consultations or
rectal cancer cases having surgery in a centre with
radiotherapy facilities.
Results: Of the 407 patients, 43% (n=175) had at
least one GP consultation between colonoscopy and
surgery. The median time from colonoscopy to surgery
was 27 days for those with an intervening GP
consultation and 15 days for those without the
consultation. 55% (n=223) had a GP consultation up
to 30 days postsurgery; it was more common in cases
of patients who consulted a GP presurgery than for
those who did not (65% and 47%, respectively,
adjusted OR 2.71, 95% CI 1.50 to 4.89, p=0.001). Of
the 142 rectal cancer cases, 23% (n=33) had their
surgery in a centre with radiotherapy facilities, with no
difference between those who did and did not consult
a GP presurgery (21% and 25% respectively, adjusted
OR 0.84, 95% CI 0.27 to 2.63, p=0.76).
Conclusions: Consulting a GP between colonoscopy
and surgery was associated with a longer interval
between diagnosis and treatment, and with further GP
consultations postsurgery, but for rectal cancer
cases it was not associated with treatment in a centre
with radiotherapy facilities. GPs might require
a more defined and systematic approach to CRC
management.
ARTICLE SUMMARY
Article focus
▪ Primary healthcare providers have an important
contribution to make in the process of colorectal
cancer management. However, in Australia, the
extent of GP involvement remains unknown as
does their level of influence on the treatment
referral pathway.
▪ We investigated the key patient clinical and
demographic characteristics associated with con-
sulting a GP between colonoscopy and surgery
(ie, between diagnosis and treatment), for
patients with colorectal cancer in New South
Wales, Australia.
▪ We also investigated whether consulting a GP
leading up to colorectal cancer surgery was
associated with time between colonoscopy and
surgery, consulting a GP after surgery or place
of treatment for rectal cancer cases.
Key messages
▪ Less than half (43%) of the patients who had a
colonoscopy and surgery consulted a GP
between the procedures; consulting a GP was
associated with poorer health.
▪ Those who consulted a GP presurgery had
longer time between colonoscopy and surgery
and more commonly consulted a GP postsur-
gery, but rectal cancer cases were no more likely
to have treatment in a centre with radiotherapy
facilities.
▪ A more well-defined approach to CRC manage-
ment by GPs might be required.
Strengths and limitations of this study
▪ A relatively large population-based sample of
patients, with reliable information on GP consul-
tations and surgical treatment for both public
and private hospitals.
▪ We could not assess other treatment types and
we did not have data on specific GP recommen-
dations or physician specialties.
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BACKGROUND
Primary healthcare providers have an important contri-
bution to make in the process of colorectal cancer
(CRC) management. General Practitioners (GPs) refer a
majority of patients with symptoms or positive screening
tests for a diagnostic colonoscopy.1 Following diagnosis,
GPs may continue to be involved in decision-making
around deﬁnitive treatment and then subsequently
during treatment, as well as in providing psychological
support and management of comorbidities and side
effects of cancer treatment.2–6 The coordination of care
during this process is difﬁcult for patients and health
professionals, given the number and complexity of the
services involved.7 Little is known about the extent of
primary healthcare worker involvement in or their level
of inﬂuence on the treatment referral pathway.
A patient may take one of multiple pathways prior and
subsequent to diagnosis,8 and the lack of a clear referral
pathway9 may increase the time to treatment. Referrals
are most frequently made to surgeons, followed by gas-
troenterologists and oncologists.10 In addition, patients
often move back and forth between services.11 12 In
Australia, GPs refer patients for diagnostic colonoscopy
and can be involved in the patient’s subsequent decision
to have treatment and post-treatment follow-up.
However, little is known about the actual level of GP
involvement in this pathway, which now also includes
referral of patients who come into the referral pathway
through the National Bowel Cancer Screening Program.
In the programme, people turning 50, 55 or 65 are
screened using a faecal occult blood test (FOBT), and
those with a positive result are sent to their GP who
refers them for further investigations.13 The relationship
between the GP and the referral specialist may also be
an important factor in determining the ongoing role of
the GP during and after treatment.14 One study
reported that the greater use of primary care prediagno-
sis is associated with better CRC outcomes,15 although it
is a complex relationship that varies across cancer
types.16
Despite the availability of clinical guidelines,17 many
CRC patients do not receive optimal care.18 19 The
choices GPs make about referral of patients in certain
health systems can have profound effects on patient out-
comes.20 A European study reported that 1-year cancer
survival was lower in health systems where the GP acted
as a ‘gatekeeper’.21 Furthermore, a recent systematic
review found a signiﬁcant relationship between hospital
case volume and short-term mortality for cancer surgery
patients.22 However, inconsistent results mean that the
relative importance of surgeon/hospital volume remains
unclear, clouding the appropriateness of using case
volume alone.22 Nevertheless, treatment in a multidiscip-
linary cancer centre with radiotherapy facilities is
important for patient care, especially for rectal cancer
cases.23–26
The aim of this study was to use linked population-
based data to describe GP involvement in the referral
pathway after diagnosis for CRC in New South Wales
(NSW), Australia. This is one part of a four-phase study
that also includes an audit of surgeons’ referral letters
and focus groups with clinicians and patients relating to
the treatment referral pathway.14 27 28 In this phase, we
sought to determine whether there is an opportunity for
GP involvement in patient care, as evidenced by GP con-
sultations in the period between diagnosis and admis-
sion for surgery. We were also interested in whether
presurgical GP consultations were associated with time
to surgery, postsurgical GP consultations or, among
rectal cancer cases, having surgery in a centre with radio-
therapy facilities.
METHODS
Data sources
The data sources and linkage process for this study have
been described in detail elsewhere.27 Brieﬂy, we used
linked records from the population-based 45 and Up
Study,29 the NSW Central Cancer Registry (CCR), the
NSW Admitted Patient Data Collection (APDC) and
claims for medical services from Medicare Australia.
The 45 and Up Study is a cohort study of 266 000 NSW
residents aged 45 years or more, sampled from the
Medicare Australia registration database.29 Participants
completed baseline questionnaires between January
2006 and May 2008 and consented to linkage to the
other data collections used here. CCR records were
obtained for people diagnosed with CRC between
January 2001 and December 2007, along with APDC
hospital separation records from July 2000 to June 2008
and claims for medical services through the Medicare
Beneﬁts Scheme (MBS) between June 2004 and January
2009.
Probabilistic linkage between the 45 and Up Study,
the CCR and the APDC was done by the Centre for
Health Record Linkage,30 as described previously, result-
ing in approximately 0.1% false-positive and <0.1% false-
negative linkages.27 MBS claims records were linked by
the Sax Institute using encrypted Medicare identiﬁcation
numbers. Ethical approvals for the 45 and Up Study, this
speciﬁc study and the linkage were given by the
University of NSW Human Research Ethics Committee
and the NSW Population and Health Services Research
Ethics Committee. The provision of Medicare records
was approved by the Department of Health and Ageing
Ethics Committee.
The group of interest comprised the 45 and Up Study
participants who were diagnosed with CRC and had a
colonoscopy leading up to their diagnosis as well as sur-
gical treatment after diagnosis. Included cases were diag-
nosed from August 2004 to December 2007 and were
linked with the APDC and MBS, so all cases had records
for treatments and consultations at least 2 months prior
to and at least 6 months after diagnosis.
The CCR provided data regarding the month and year
of diagnosis, age, place of residence at diagnosis, disease
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stage (localised, regional, distant metastases or
unknown) and cancer site (colon, or rectum including
the rectosigmoid junction). We identiﬁed patients’
comorbidities from APDC diagnosis codes, including
cardiovascular disease, chronic obstructive pulmonary
disease (COPD), diabetes and other diseases in the
Charlson Comorbidity Index (other key comorbid-
ities).31 Other sociodemographic characteristics (in
table 1) were obtained from the self-completed 45 and
Up Study baseline questionnaire.
Procedures and consultations
A specialist clinical panel identiﬁed relevant procedure
codes and items for consultations, colonoscopies and
surgery in the APDC and MBS. GP consultations were
indicated by MBS items 1–51, 601–603, 700–719, 5000–
5067 and 10 996–10 997. Surgical treatment comprised
hemicolectomies, total colectomies, partial colectomies,
total proctocolectomies, anterior rectal resections,
Hartmann’s procedure (rectosigmoidectomy), abdomi-
noperineal resections and ‘other’ resections of the
colon or rectum. Previous studies have shown that these
data sources record over 90% of colonoscopies and sur-
gical treatments for patients with cancer.32 33
Chemotherapy and radiotherapy are generally per-
formed on an outpatient basis, for which data were not
available, so they were not included in this study.
Diagnosis dates were available as month and year only,
so chronology around diagnosis was based on calendar
month and year. However, we were able to analyse the
actual dates of GP consultations from the MBS and col-
onoscopies and surgeries from the APDC and MBS. We
included surgical procedures performed in or after the
month of diagnosis, and the last presurgery colonoscopy
no earlier than 2 months prior to the month of diagno-
sis. For GP consultations occurring between colonoscopy
and surgery, only consultations from the day of colonos-
copy and at least 2 days prior to surgery were consid-
ered, to allow for the consultation to have an impact on
the treatment pathway and to exclude consultations that
were most likely for preoperative checks.
Outcomes
The primary outcome was the pattern of GP consulta-
tions between colonoscopy and surgery. This was then
used as the key study factor in examining time between
colonoscopy and surgery, patterns of GP consultations
following surgery and, for rectal cancer cases, receiving
surgery in a centre with radiotherapy facilities.
Statistical analysis
χ2 tests were used to compare patient groups and uncon-
ditional multivariable logistic regression identiﬁed
factors associated with the outcomes of interest. Cox’s
proportional hazards regression was used to investigate
factors associated with time between colonoscopy and
surgery. Factors of interest included patient characteris-
tics such as age, disease stage and place of residence.
Consultation of a GP between diagnosis and treatment
was analysed for associations with time to surgery, having
a GP consultation after surgery and, for rectal cancer
cases, having treatment in a centre with radiotherapy
facilities. Having a specialist consultation was considered
a possible confounder and was included as a covariate. A
small number of patients with missing values for vari-
ables of interest were excluded from analyses. All ana-
lyses were carried out in SAS V.9.1 (SAS Institute Inc,
Cary, North Carolina, USA).
RESULTS
The study sample has been described in detail else-
where.27 Brieﬂy, 1023 CRC cases diagnosed between
January 2001 and December 2007 were identiﬁed from
the CCR among the ﬁrst 102 938 participants in the 45
and Up Study. The sample was restricted to 569 CRC
cases diagnosed from August 2004 to December 2007
whose identiﬁers linked to the APDC and MBS. Of
these, 407 cases (72%) received surgery in or after the
month of diagnosis and had a previous colonoscopy (up
to 2 months before the month of diagnosis) (ﬁgure 1).
These 407 cases are the ones in whose GP consultations
we were interested; their characteristics are described in
table 1.
GP consultations between diagnosis and treatment
Forty-three per cent (n=175) of the 407 cases had at
least one GP consultation between diagnosis and treat-
ment (ﬁgure 2), with 23% having one consultation,
10% having two consultations and 9% having three or
more consultations during that period. There were
higher odds of consulting a GP between diagnosis and
treatment for those who consulted a specialist prior to
surgery, along with those reporting poorer health, those
with diabetes, those without COPD, ever smokers and
those who were diagnosed with CRC after participating
in the 45 and Up Study (table 1).
Time between diagnosis and treatment
The median time from colonoscopy to surgery was
19 days; it was 27 days for those with and 15 days for
those without an intervening GP consultation (ﬁgure 2).
The time to surgery was more than 28 days for 43% of
cases consulting a GP compared to 15% of patients who
did not consult a GP. For those consulting a GP, the
median time from colonoscopy to the ﬁrst GP consult-
ation was 7 days, and the median time of the last consult-
ation prior to surgery was 10 days (including multiple
GP consultations, excluding those 1 or 2 days presur-
gery). After adjusting for all covariates, the time from
diagnosis to treatment remained signiﬁcantly longer for
patients who consulted a GP between diagnosis and
treatment than for those who did not. This was also true
for those who consulted a specialist between diagnosis
and treatment compared with those who did not, and
for rectal cancer cases compared with colon cancer
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Table 1 Characteristics of colorectal cancer (CRC) cases diagnosed between August 2004 and December 2007 that had
colonoscopy and surgery, and characteristics associated with consulting a GP between colonoscopy and surgery (N=407)
GP consult
Adjusted OR* 95% CI*Category n n Per cent p Value†
Sex 0.79
Woman 152 64 42 1.10 0.56 to 2.15
Man 255 111 44 1.00 (ref)
Age 0.77
<60 78 28 36 1.38 0.58 to 3.30
60–69 108 42 39 1.13 0.57 to 2.28
70–79 150 75 50 1.00 (ref)
80+ 71 30 42 1.50 0.62 to 3.65
Country of birth 0.09
Australia 320 141 44 1.00 (ref)
Other 81 30 37 0.50 0.22 to 1.12
Unknown 6 4 67 Not incl. Not incl.
Language spoken at home 0.41
English 377 163 43 1.00 (ref)
Non-English 30 12 40 0.59 0.17 to 2.06
Place of residence at diagnosis 0.62
Metropolitan 186 75 40 1.00 (ref)
Other urban 103 45 44 0.63 0.24 to 1.62
Rural 118 55 47 1.65 0.58 to 4.69
Type of housing 0.93
House 296 130 44 1.00 (ref)
Flat/unit 50 19 38 1.17 0.46 to 2.93
House on farm 28 12 43 1.22 0.40 to 3.66
Elderly accommodation 26 11 42 0.79 0.24 to 2.58
Other/unspecified 7 3 43 Not incl. Not incl.
Socioeconomic status 0.27
Least disadvantaged quintile 143 54 38 1.00 (ref)
Quintile 2 64 28 44 1.65 0.58 to 4.69
Quintile 3 126 55 44 1.17 0.43 to 3.21
Quintile 4 58 28 48 2.40 0.87 to 6.60
Most disadvantaged quintile 16 10 63 3.18 0.63 to 16.01
Highest education level attained 0.27
No school certificate/other 48 22 46 1.20 0.47 to 3.09
School/intermediate certificate 102 41 40 1.00 (ref)
Higher school/leaving certificate 28 12 43 1.49 0.47 to 4.67
Trade/apprenticeship 56 21 38 1.01 0.40 to 2.55
Certificate/diploma 83 36 43 1.47 0.63 to 3.43
University degree or higher 80 37 46 2.94 1.19 to 7.26
Unspecified 10 6 60 Not incl. Not incl.
Marital status 0.08
Married/living as married 288 120 42 1.00 (ref)
Single/divorced/separated 51 28 55 2.65 1.11 to 6.30
Widowed 65 26 40 1.03 0.44 to 2.39
Unspecified 3 1 33 Not incl. Not incl.
Income level 0.11
<$20K p.a. 112 51 46 1.00 (ref)
$20K–<$40K p.a. 83 45 54 1.79 0.76 to 4.25
$40K–<$70K p.a. 62 22 35 0.68 0.26 to 1.75
$70K+ p.a. 52 15 29 0.56 0.19 to 1.68
Unspecified 98 42 43 0.74 0.33 to 1.67
Health insurance 0.19
Private with extras 190 83 44 1.00 (ref)
Private no extras 70 26 37 0.45 0.21 to 0.97
DVA/healthcare card 101 46 46 1.20 0.55 to 2.62
None of these 37 16 43 0.67 0.24 to 1.85
Missing 9 4 44 1.24 0.24 to 6.47
Continued
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cases (table 2). Separate analyses for colon and rectal
cancer cases found that for both cancer types there was
a longer time to surgery for those consulting a GP or a
specialist between diagnosis and treatment (table 3).
GP consultations after treatment
Twenty-six per cent (26%, n=106) of cases had a GP con-
sultation up to 2 weeks postsurgery, 55% (n=223) con-
sulted a GP up to 30 days postsurgery and 80% (n=327)
consulted a GP up to 3 months postsurgery. After
Table 1 Continued
GP consult
Adjusted OR* 95% CI*Category n n Per cent p Value†
BMI‡ 0.21
Underweight/normal (<25 kg/m2) 155 59 38 1.00 (ref)
Overweight (25–≤30 kg/m2) 157 69 44 1.56 0.83 to 2.93
Obese/morbidly obese (≥30 kg/m2) 66 31 47 1.30 0.58 to 2.94
Null/not specified 29 16 55 2.93 0.98 to 8.74
Smoking status 0.05
Never smoker 203 80 39 1.00 (ref)
Ever smoker 204 95 47 1.81 1.01 to 3.26
Self-reported health status 0.002
Good–excellent 307 115 37 1.00 (ref)
Fair/poor 78 47 60 2.76 1.30 to 5.82
Unspecified 22 13 59 5.60 1.59 to 19.81
Cardiovascular disease 0.11
Yes 47 26 55 2.09 0.85 to 5.13
No 360 149 41 1.00 (ref)
COPD 0.04
Yes 29 10 34 0.30 0.09 to 0.95
No 378 165 44 1.00 (ref)
Diabetes 0.001
Yes 50 33 66 5.15 2.02 to 13.16
No 357 142 40 1.00 (ref)
Other key comorbidities 0.88
Yes 56 26 46 0.94 0.40 to 2.18
No 351 149 42 1.00 (ref)
Family history of CRC 0.51
Yes 75 37 49 1.27 0.63 to 2.57
No 332 138 42 1.00 (ref)
Disease stage 0.08
Localised 185 73 39 1.00 (ref)
Regional 176 76 43 1.66 0.91 to 3.02
Distant metastases 27 13 48 1.57 0.47 to 5.19
Unknown 19 13 68 5.05 1.35 to 18.91
Cancer site 0.52
Colon 265 114 43 1.00 (ref)
Rectum 142 61 43 1.21 0.68 to 2.18
Year of diagnosis 0.64
2004 43 17 40 1.24 0.46 to 3.36
2005 113 43 38 0.93 0.44 to 1.93
2006 111 56 50 1.46 0.72 to 2.95
2007 140 59 42 1.00 (ref)
Timing of CRC diagnosis relative to the 45 and Up Study questionnaire 0.01
Before (prevalent) 327 131 40 0.35 0.16 to 0.75
After (incident) 80 44 55 1.00 (ref)
Specialist consultation between colonoscopy and surgery <0.0001
Yes 285 156 55 17.64 7.71 to 40.34
No 122 19 16 1.00 (ref)
*Adjusted for all other variables in this table.
†Overall p value from a multivariable logistic regression.
‡Calculated from self-reported weight (kg)/height (m)2.
BMI, body mass index; CRC, colorectal cancer; COPD, chronic obstructive pulmonary disease; DVA, Department of Veterans’ Affairs;
GP, general practitioner; Not incl.: this category was not included in logistic regression (n=26 overall); Ref: reference category.
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adjusting for all covariates, patients who consulted a GP
in the interval between diagnosis and treatment were
more likely to consult a GP in the 30 days postsurgery
(65% vs 47% for those not consulting a GP presurgery,
OR 2.71, 95% CI 1.50 to 4.89, p=0.001).
Rectal cancer surgery in a centre with radiotherapy
facilities
Of the 142 rectal cancer cases, 23% (n=33) had their
surgery in a centre with radiotherapy facilities, 21% of
those with and 25% of those without a presurgery GP
consultation. After adjusting for key characteristics, there
was no association between consulting a GP presurgery
and having the surgery in a centre with radiotherapy
facilities (OR 0.84 vs no presurgical GP consultation,
95% CI 0.64 to 2.35, p=0.54). An additional 21% had
their surgery in a hospital colocated with a centre that
had radiotherapy facilities, and a further 8% had a non-
surgical admission to a centre with radiotherapy facilities
within the study period.
DISCUSSION
Around two in ﬁve newly-diagnosed CRC cases who had
colonoscopy and surgery had a GP consultation between
diagnosis and treatment, potentially allowing the GP to
have some inﬂuence on individual patient treatment
pathways. Having a GP consultation during this period
was associated with longer time to surgery (but not
necessarily causally) and consulting a GP postsurgery,
but for rectal cancer cases it was not associated with
treatment in a centre with radiotherapy facilities.
Having a GP consultation between diagnosis and treat-
ment was more likely for cases with poorer self-reported
health, those with diabetes, those without COPD and
those who had ever been a smoker. Almost half of the
patients who consulted a GP between diagnosis and
treatment had more than one consultation during this
time period. This suggests that GP consultations may be
occurring for the most appropriate group: coordinating
the care of those patients at higher risk because of poor
general health.
The time from colonoscopy to surgery was substan-
tially longer (a difference in medians of 12 days) for
patients who consulted a GP between diagnosis and
treatment, even after adjustment for cancer site,
comorbidities, disadvantage and health status. However,
we were unable to determine whether there was a causal
link between GP consultations and time to surgery; it
may be that a longer time period simply allows a greater
opportunity for GP consultations in the interval. It could
also be due to more patients who consulted a GP having
presurgical radiotherapy. If increased time to surgery
was a consequence of the engagement of the GP, this
may have allowed a more considered decision by the GP
about the optimal referral pathway with the increased
interval being unlikely to have a material inﬂuence on
the physical outcome, although it may raise psycho-
logical issues for the patient.34 35 It is worth considering
if there are other ways in which GPs could be involved
in decisions regarding care following diagnosis that do
not increase the interval between diagnosis and treat-
ment. This might include arranging follow-up GP visits
sooner after the colonoscopy, especially as the ﬁrst GP
consultation was a median of 7 days afterwards. It might
also include earlier email, text or telephone communica-
tion between the GP and the patient to initiate a
referral.
Having a GP consultation after surgery was more likely
for patients who consulted a GP in the lead-up to
surgery, suggesting a greater continuity of primary care
for these cases. Again, this might be especially appropri-
ate for those who had comorbidities or poorer health
status. It might also assist lower socioeconomic patients
who, because of poorer health literacy, may have had
more difﬁculty navigating the complexities of the health-
care system.
Given the importance of being able to offer radiother-
apy for rectal cancer,17 we investigated any potential
association between presurgical GP consultations and
Figure 1 Selection of cases with colorectal cancer for
analysis.
Figure 2 Flowchart of procedures and consultations for the
407 colorectal cancer cases who had a colonoscopy and
surgery.
6 Goldsbury D, Harris M, Pascoe S, et al. BMJ Open 2013;3:e002325. doi:10.1136/bmjopen-2012-002325
Colorectal cancer referral pathways
Table 2 Demographic and clinical characteristics associated with time between colonoscopy and colorectal cancer (CRC)
surgery for all CRC cases (N=407)
Category n Median time (days) IQR (days) Adjusted HR* 95% CI* p Value†
GP consultation between colonoscopy and surgery <0.0001
Yes 175 27 18–42 0.44 0.34 to 0.58
No 232 15 8–23 1.00 (ref)
Specialist consultation between colonoscopy and surgery 0.002
Yes 285 21 14–35 0.62 0.47 to 0.84
No 122 13 7–22 1.00 (ref)
Sex 0.53
Woman 152 19 12–28 1.10 0.82 to 1.46
Man 255 20 12–31 1.00 (ref)
Age 0.33
<60 78 17 8–29 0.78 0.54 to 1.13
60–69 108 19 13–32 0.80 0.59 to 1.09
70–79 150 21 12–29 1.00 (ref)
80+ 71 20 12–28 1.05 0.73 to 1.52
Country of birth 0.34
Australia 320 19 13–29 1.00 (ref)
Other 81 19 8–30 0.85 0.61 to 1.19
Unknown 6 12 10–40 Not incl. Not incl.
Language spoken at home 0.20
English 377 19 12–29 1.00 (ref)
Non-English 30 21 10–38 1.40 0.84 to 2.31
Place of residence at diagnosis 0.95
Metropolitan 186 19 11–28 1.00 (ref)
Other urban 103 20 13–28 1.07 0.71 to 1.63
Rural 118 20 11–33 1.04 0.69 to 1.57
Type of housing 0.63
House 296 19 12–29 1.00 (ref)
Flat/unit 50 19 10–29 0.93 0.64 to 1.35
House on farm 28 21 12–48 0.76 0.48 to 1.20
Elderly accommodation 26 22 17–42 0.86 0.53 to 1.40
Other/unspecified 7 29 19–31 Not incl. Not incl.
Socioeconomic status 0.13
Least disadvantaged quintile 143 17 11–28 1.00 (ref)
Quintile 2 64 20 12–34 0.94 0.60 to 1.46
Quintile 3 126 20 8–29 1.24 0.80 to 1.92
Quintile 4 58 22 14–33 0.82 0.53 to 1.26
Most disadvantaged quintile 16 22 14–27 1.60 0.80 to 3.19
Highest education level attained 0.53
No school certificate/other 48 20 14–31 1.09 0.74 to 1.60
School/intermediate certificate 102 22 16–33 1.00 (ref)
Higher school/leaving certificate 28 18 12–34 0.96 0.59 to 1.56
Trade/apprenticeship 56 18 13–28 1.36 0.92 to 2.00
Certificate/diploma 83 20 10–29 0.94 0.68 to 1.32
University degree or higher 80 16 8–36 1.16 0.80 to 1.70
Unspecified 10 13 3–22 Not incl. Not incl.
Marital status 0.09
Married/living as married 288 24 12–37 1.00 (ref)
Single/divorced/separated 51 18 11–28 1.04 0.72 to 1.52
Widowed 65 22 17–34 0.69 0.48 to 0.97
Unspecified 3 20 9–21 Not incl. Not incl.
Income level 0.11
<$20K p.a. 112 21 14–31 1.00 (ref)
$20K–<$40K p.a. 83 21 13–31 1.03 0.71 to 1.49
$40K–<$70K p.a. 62 18 9–35 0.83 0.56 to 1.23
$70K+ p.a. 52 13 8–29 1.50 0.95 to 2.35
Unspecified 98 19 13–28 1.19 0.85 to 1.66
Continued
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surgery in hospitals with radiotherapy facilities, reﬂect-
ing another aspect of continuity of care. For rectal
cancer cases, having a GP consultation prior to surgery
was not associated with having a surgical procedure in a
centre with radiotherapy facilities. Fewer than one in
four had their surgery in a centre with radiotherapy
facilities, although this increased to around one in two
when allowing for surgery in hospitals colocated with
Table 2 Continued
Category n Median time (days) IQR (days) Adjusted HR* 95% CI* p Value†
Health insurance 0.42
Private with extras 190 18 9–28 1.00 (ref)
Private no extras 70 17 11–28 1.01 0.73 to 1.40
DVA/healthcare card 101 21 14–29 0.90 0.66 to 1.24
None of these 37 28 19–41 0.67 0.44 to 1.03
Missing 9 25 16–28 1.09 0.51 to 2.33
BMI‡ 0.48
Underweight/normal (<25kg/m2) 155 18 10–28 1.00 (ref)
Overweight (25–<30 kg/m2) 157 20 12–35 0.86 0.66 to 1.13
Obese/morbidly obese (≥30 kg/m2) 66 22 13–31 0.95 0.68 to 1.34
Null/Not specified 29 19 11–29 0.72 0.45 to 1.15
Smoking status 0.33
Never smoker 203 19 10–29 1.00 (ref)
Ever smoker 204 19 12–30 1.13 0.89 to 1.44
Self-reported health status 0.37
Good–excellent 307 18 11–29 1.00 (ref)
Fair/poor 78 21 15–40 0.89 0.64 to 1.23
Unspecified 22 22 14–28 0.70 0.41 to 1.21
Cardiovascular disease 0.77
Yes 47 20 9–29 0.95 0.65 to 1.38
No 360 19 12–30 1.00 (ref)
COPD 0.47
Yes 29 20 11–27 1.19 0.74 to 1.92
No 378 19 12–30 1.00 (ref)
Diabetes 0.18
Yes 50 26 14–36 1.30 0.89 to 1.90
No 357 19 11–29 1.00 (ref)
Other key comorbidities 0.67
Yes 56 20 12–29 1.08 0.76 to 1.52
No 351 19 12–30 1.00 (ref)
Family history of CRC 0.99
Yes 75 20 13–33 1.00 0.75 to 1.34
No 332 19 12–29 1.00 (ref)
Disease stage 0.08
Localised 185 19 13–29 1.00 (ref)
Regional spread 176 19 10–29 1.16 0.91 to 1.48
Distant metastases 27 20 12–39 0.73 0.43 to 1.21
Unknown 19 35 13–48 0.65 0.37 to 1.16
Cancer site <0.0001
Colon 265 18 10–27 1.00 (ref)
Rectum 142 22 14–37 0.58 0.45 to 0.74
Year of diagnosis 0.53
2004 43 19 9–26 1.32 0.86 to 2.02
2005 113 19 12–29 1.01 0.75 to 1.37
2006 111 21 14–32 1.13 0.84 to 1.52
2007 140 18 11–32 1.00 (ref)
Timing of CRC diagnosis relative to the 45 and Up questionnaire 0.61
Before (prevalent) 327 19 11–29 1.09 0.79 to 1.50
After (incident) 80 21 14–31 1.00 (ref)
*Adjusted for all other variables in this table (HR<1 indicates longer time between colonoscopy and surgery).
†Overall p Value from the Cox proportional hazards regression.
‡Calculated from self-reported weight (kg)/height (m)2.
BMI, body mass index; CRC, colorectal cancer; DVA, Department of Veterans’ Affairs; GP, general practitioner; COPD, chronic obstructive
pulmonary disease; IQR, interquartile range; Not incl.: this category was not included in proportional hazards regression (n=26 overall);
ref: reference category.
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another hospital that has a radiotherapy centre. Others
have previously reported the potential underutilisation
of specialist cancer centres for patients with rectal
cancer.25 26
This study is subject to a number of limitations. The
45 and Up Study had a response rate of 18% (similar to
other cohort studies of this nature) and oversampled
people from rural areas. While the 45 and Up Study par-
ticipants resemble the general population in many
respects, they are in general of higher socioeconomic
status and more ‘healthy’.36 However, empirical data
from the study show risk estimates relating to a wide
range of exposures and outcomes in the cohort are very
similar to those calculated using ‘representative’ popula-
tion survey data.36 We did not include treatment with
chemotherapy or with radiotherapy as the available data
were not comprehensive for all people receiving these
treatments, and nor did we have information on
patients’ decisions regarding treatment. These may have
inﬂuenced the place of treatment and explained some
of the differences in the time to surgery. We analysed
rectal cancer surgery in hospitals with radiotherapy facil-
ities as an indicator that all cancer treatment modalities
were available at one centre, thereby making it a more
comprehensive cancer facility. This could have been
improved with information regarding patients’ decisions,
GPs’ recommendations and the specialties of all physi-
cians involved in the care of each patient.
It is difﬁcult to sort out the cause and effect of GP
visits and an increased interval between diagnosis and
treatment using these data alone as the Medicare data
do not identify the reasons for GP visits. It may have
been in relation to CRC or some other preexisting
illness. Similarly, we could not determine the nature of
Table 3 Demographic and clinical characteristics associated with time between colonoscopy and colorectal cancer surgery,
for colon and rectum cancer cases
Colon cancer (n=265) Rectal cancer (n=142)
Category Adjusted HR* 95% CI p Value† Adjusted HR* 95% CI p Value†
GP consultation between colonoscopy and surgery 0.001 <0.0001
Yes 0.54 0.38 to 0.79 0.25 0.13 to 0.48
No 1.00 (ref) 1.00 (ref)
Specialist consultation between colonoscopy and surgery 0.01 0.01
Yes 0.57 0.38 to 0.86 0.41 0.21 to 0.79
No 1.00 (ref) 1.00 (ref)
Country of birth‡ 0.36 0.01
Australia 1.00 (ref) 1.00 (ref)
Other 1.22 0.80 to 1.87 0.37 0.17 to 0.78
Marital status‡ 0.28 0.02
Married/living as married 1.00 (ref) 1.00 (ref)
Single/divorced/separated 0.92 0.54 to 1.58 1.52 0.70 to 3.26
Widowed 0.68 0.42 to 1.10 0.42 0.20 to 0.86
Income level 0.13 0.03
<$20K p.a. 1.00 (ref) 1.00 (ref)
$20K–<$40K p.a. 0.78 0.46 to 1.31 0.65 0.32 to 1.33
$40K–<$70K p.a. 0.85 0.50 to 1.44 0.30 0.12 to 0.75
$70K+ p.a. 1.62 0.88 to 2.99 0.52 0.19 to 1.41
Unspecified 0.91 0.58 to 1.42 1.07 0.52 to 2.21
Health insurance 0.02 0.01
Private with extras 1.00 (ref) 1.00 (ref)
Private no extras 0.67 0.43 to 1.04 1.71 0.88 to 3.33
DVA/healthcare card 0.54 0.36 to 0.80 3.36 1.56 to 7.24
None of these 0.51 0.27 to 0.95 0.79 0.35 to 1.78
Missing 0.46 0.14 to 1.58 2.09 0.63 to 6.99
Disease stage 0.02 0.72
Localised 1.00 (ref) 1.00 (ref)
Regional spread 1.17 0.85 to 1.62 0.79 0.48 to 1.30
Distant metastases 0.66 0.35 to 1.25 0.60 0.18 to 2.01
Unknown 0.43 0.21 to 0.89 1.13 0.29 to 4.38
*Adjusted for all other variables in this table, as well as for sex, age, language spoken at home, place of residence at diagnosis, type of
housing, socioeconomic status, education level, BMI, smoking status, self-reported health status, comorbidities, family history of colorectal
cancer, year of diagnosis and diagnosis before/after completing study questionnaire. The variables not shown in the table were not associated
with time to surgery for colon or rectal cancers. HR<1 indicates longer time between colonoscopy and surgery.
†Overall p Value from the Cox proportional hazards regression.
‡Excludes missing values (n=6 for country of birth, n=3 for marital status, n=9 overall).
MBI, body mass index; GP, general practitioner; DVA, Department of Veterans’ Affairs; Ref: reference category.
Goldsbury D, Harris M, Pascoe S, et al. BMJ Open 2013;3:e002325. doi:10.1136/bmjopen-2012-002325 9
Colorectal cancer referral pathways
specialist consultations, and a longer time to surgery for
those with a specialist consultation could be beneﬁcial if
it means patients are getting the most appropriate treat-
ment. Furthermore, we did not have information on
individual physicians or their specialties, so we could not
assess other aspects potentially related to the referral
pathway, such as whether the colonoscopy was per-
formed by a gastroenterologist or a surgeon, or whether
the same surgeon then carried out the surgical
procedure.
The National Bowel Cancer Screening Program was
started in August 2006,13 but this study does not fully
address what happens in the presence of the screening
programme. In this programme, a GP refers a patient to
colonoscopy after a positive FOBT result and is then
involved in the referral process for cases diagnosed with
CRC. The programme is being expanded to include
people in other age groups,13 giving a further opportun-
ity for GP involvement. This means that there is some
urgency to optimise the potential beneﬁts of engage-
ment of GPs (eg, in providing better guidance about
where to refer), and a need to address the potential
reasons for an increased interval between diagnosis and
treatment associated with consulting a GP, especially for
patients with rectal cancer.
Conclusion
This is one of the ﬁrst studies to examine the role of the
GP in the pathway following CRC diagnosis and prior to
surgery. Less than half of the patients had a GP consult-
ation in this period, but those who did appeared to be
among those who most needed it. The association
between consulting a GP pretreatment and posttreat-
ment is a strong rationale for GP engagement in the
early stages of the patient pathway and will improve long-
term continuity of care. Further research is needed to
explore the directions of the association between GP
visits and the interval between diagnosis and treatment.
However, a more systematic approach might be needed
for GP involvement in the treatment pathway, perhaps
including ofﬁcial guidelines from primary care/GP orga-
nisations. This would not only encourage GP involve-
ment, but it would also ensure that this does not lead to
unnecessary delays.
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